Literature DB >> 20129783

Podophyllotoxin analogues active versus Trypanosoma brucei.

Md Jashim Uddin1, David C Smithson, Kristin M Brown, Brenda C Crews, Michele Connelly, Fangyi Zhu, Lawrence J Marnett, R Kiplin Guy.   

Abstract

In an effort to discover novel anti-trypanosomal compounds, a series of podophyllotoxin analogues coupled to non-steroidal anti-inflammatory drugs (NSAIDs) has been synthesized and evaluated for activity versus Trypanosoma brucei and a panel of human cell lines, revealing compounds with low nano-molar potencies. It was discovered that coupling of NSAIDs to podophyllotoxin increased the potencies of both compounds over 1300-fold. The compounds were shown to be cytostatic in nature and seem to act via de-polymerization of tubulin in a manner consistent with the known activities of podophyllotoxin. The potencies against T. brucei correlated directly with LogP values of the compounds, suggesting that the conjugates are acting as hydrophobic tags allowing podophyllotoxin to enter the cell. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129783      PMCID: PMC2826502          DOI: 10.1016/j.bmcl.2010.01.009

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B' helix defines substrate preferences of sterol 14alpha-demethylase.

Authors:  Galina I Lepesheva; Natalia G Zaitseva; W David Nes; Wenxu Zhou; Miharu Arase; Jialin Liu; George C Hill; Michael R Waterman
Journal:  J Biol Chem       Date:  2005-11-30       Impact factor: 5.157

2.  Receptors for the host low density lipoproteins on the hemoflagellate Trypanosoma brucei: purification and involvement in the growth of the parasite.

Authors:  I Coppens; P Baudhuin; F R Opperdoes; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  The phenomenon of treatment failures in Human African Trypanosomiasis.

Authors:  R Brun; R Schumacher; C Schmid; C Kunz; C Burri
Journal:  Trop Med Int Health       Date:  2001-11       Impact factor: 2.622

4.  Biodiversity of CYP51 in trypanosomes.

Authors:  G I Lepesheva; T Y Hargrove; R D Ott; W D Nes; M R Waterman
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

5.  Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.

Authors:  Mary E Konkle; Tatiana Y Hargrove; Yuliya Y Kleshchenko; Jens P von Kries; Whitney Ridenour; Md Jashim Uddin; Richard M Caprioli; Lawrence J Marnett; W David Nes; Fernando Villalta; Michael R Waterman; Galina I Lepesheva
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

6.  Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.

Authors:  Galina I Lepesheva; Robert D Ott; Tatiana Y Hargrove; Yuliya Y Kleshchenko; Inge Schuster; W David Nes; George C Hill; Fernando Villalta; Michael R Waterman
Journal:  Chem Biol       Date:  2007-11

Review 7.  Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  Prog Lipid Res       Date:  2004-01       Impact factor: 16.195

8.  Endocytosis of a glycosylphosphatidylinositol-anchored protein via clathrin-coated vesicles, sorting by default in endosomes, and exocytosis via RAB11-positive carriers.

Authors:  Christoph G Grünfelder; Markus Engstler; Frank Weise; Heinz Schwarz; York-Dieter Stierhof; Gareth W Morgan; Mark C Field; Peter Overath
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

9.  Evidence for novel cell cycle checkpoints in trypanosomes: kinetoplast segregation and cytokinesis in the absence of mitosis.

Authors:  A Ploubidou; D R Robinson; R C Docherty; E O Ogbadoyi; K Gull
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

10.  Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei.

Authors:  B K Kubata; M Duszenko; Z Kabututu; M Rawer; A Szallies; K Fujimori; T Inui; T Nozaki; K Yamashita; T Horii; Y Urade; O Hayaishi
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

View more
  2 in total

1.  Antitumor Activity of Cytotoxic Cyclooxygenase-2 Inhibitors.

Authors:  Md Jashim Uddin; Brenda C Crews; Shu Xu; Kebreab Ghebreselasie; Cristina K Daniel; Philip J Kingsley; Surajit Banerjee; Lawrence J Marnett
Journal:  ACS Chem Biol       Date:  2016-09-19       Impact factor: 5.100

2.  Targeted Detection of Cyclooxygenase-1 in Ovarian Cancer.

Authors:  Paola Malerba; Brenda C Crews; Kebreab Ghebreselasie; Cristina K Daniel; Elma Jashim; Ansari M Aleem; Redoan A Salam; Lawrence J Marnett; Md Jashim Uddin
Journal:  ACS Med Chem Lett       Date:  2019-07-24       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.